← all works
Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study
Why is this work in the frame?
A frame that forgets how it found something cannot be audited. These are the routes that admitted this work.
Canadian affiliationAn author listed a Canadian institution. This is the only route the usual frame has.
Abstract
No abstract. This is not a gap in this database — OpenAlex has none either. 23.3% of the frame is in this state, and the screen finds HALF as much metaresearch here, so the absence is a measured bias rather than a missing field.
The record
- Venue
- The Lancet Oncology
- Topic
- Lung Cancer Diagnosis and Treatment
- Field
- Medicine
- Canadian institutions
- Ottawa Hospital
- Funders
- National Cancer Institute
- Keywords
- CarboplatinMedicineCetuximabPaclitaxelOncologyRadiation therapyStage (stratigraphy)Internal medicineLung cancerChemotherapyNuclear medicineCancerCisplatinColorectal cancer
- Has abstract in OpenAlex
- no